SCHEMBL4906221

SCHEMBL4906221

CCN(c1ccc(OCc2cc(F)cc(F)c2)cc1)S(=O)(=O)c1ccc(C)c(C(=O)OC)c1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MMP9 P14780 2/20 0.47
ADAM17 P78536 2/20 0.47
MMP2 P08253 1/20 0.47
MMP14 P50281 1/20 0.47
LMNA P02545 2/20 0.44
MAPT P10636 2/20 0.44
ALDH1A1 P00352 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
TSHR P16473 2/20 0.41
KDM4E B2RXH2 1/20 0.41
KEAP1 Q14145 2/20 0.41
NFE2L2 Q16236 2/20 0.41
ATM Q13315 1/20 0.41
MMP13 P45452 1/20 0.41
ESR1 P03372 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
GSK3B P49841 1/20 0.40
BACE1 P56817 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4904032 0.93 KEAP1 (0.49) MMP9ADAM17MMP2MMP14LMNA
SCHEMBL4906576 0.91 MMP2 (0.45) MMP9ADAM17MMP2MMP14LMNA
SCHEMBL4904188 0.90 LMNA (0.53) MMP9ADAM17MMP2MMP14LMNA
SCHEMBL4904214 0.90 MMP13 (0.46) MMP9ADAM17LMNAMAPTALDH1A1
SCHEMBL4908025 0.90 MMP9 (0.42) MMP9ADAM17MMP2MMP14LMNA
SCHEMBL4906453 0.89 LMNA (0.48) MMP9ADAM17LMNAMAPTALDH1A1
SCHEMBL4905129 0.89 MMP13 (0.52) MMP9ADAM17LMNAMAPTALDH1A1
SCHEMBL4902970 0.89 KEAP1 (0.48) MMP9ADAM17LMNAMAPTALDH1A1
SCHEMBL4895775 0.87 ALDH1A1 (0.48) MMP9ADAM17MMP2MMP14LMNA
SCHEMBL4899758 0.86 MMP2 (0.49) MMP9MMP2LMNAMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD MMP9 4666/4885ADAM17 4821/4885MMP2 4348/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD MMP9 4632/4885ADAM17 4813/4885MMP2 4105/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD MMP9 4632/4885ADAM17 4813/4885MMP2 4105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.